000 04933cam a2200445 i 4500
001 200454102
999 _c200454102
_d72314
003 TR-AnTOB
005 20241115090248.0
006 m o d
007 cr cnuaaaau
008 201001s2021 nju ob 001 0 eng
020 _a9781119524649
_q(paperback)
020 _z9781119524656
_q(e-book)
020 _z9781119524670
_q(epub)
020 _z9781119524687
_q(o-book)
040 _aDNLM/DLC
_beng
_erda
_cDLC
_dTR-AnTOB
041 0 _aeng
060 0 0 _aW 20.55.C5
_bM149 2021
096 _aW20.55.C5
_bM149 2021 EBK
100 1 _aMachin, David
_eauthor
_9143144
245 1 0 _aRandomised clinical trials :
_bdesign, practice and reporting /
_cDavid Machin, Peter M. Fayers, Bee Choo Tai.
250 _aSecond edition
264 1 _aNew Jersey :
_bWiley-Blackwell,
_c2021.
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aİncludes index.
505 0 _aDesign Features -- The Trial Protocol -- Measurement and Data Capture -- Randomisation -- Trial Initiation -- Trial Conduct and Completion -- Basics for Analysis -- Trial Size -- Data and Safety Monitoring -- Reporting -- More than Two Interventions -- Paired and Matched Designs -- Repeated Measures Design -- Non-Inferiority and Equivalence Trials -- Cluster Designs -- Stepped Wedge Designs -- Genomic Targets -- Feasibility and Pilot Studies -- Further Topics.
520 _a"It is now more than ten years since the first edition of this book was published. In the intervening years, while many things have remained unchanged, there have also been many new developments over the period. This second edition refreshes the first, refining some of the sections to better explain their contents and, at the same time, replacing some examples with more current illustrations. To reflect the changes, we have created new chapters by splitting and then expanding old chapters. Thus, we now include full chapters on data and safety monitoring including interim analyses of accumulating data, cluster designs, repeated measures, and non-inferiority designs as there has been a rapid increase in the use of such trial designs along with some methodological developments and improvements in statistical software available for analysis. In addition, we have included entirely new chapters on stepped wedge designs, genomic targets and, feasibility and pilot studies. The chapter on stepped wedge designs reflects the growing importance of such complex intervention designs while that on genomic targets highlights the research focus directed towards more individualised medicine. In contrast the new chapter concerned with feasibility and pilot studies brings us back to the early planning stages of the clinical trial which is planned. The chapter is included as there is increasing recognition that perhaps a more structured approach is required at the planning stage of any proposed trial. The intention is to help avoid the conduct of clinical trials which fail due to the basic assumptions made at the planning stage being inappropriate. This edition is divided into three sections: I Basic Considerations, II Adaptions of the Basic Design, and III Further Topics. As the title suggests, the first section is intended to cover topics that are relevant to all randomised trials of whatever design and complexity. Thus, it may be the key section for those who are new to clinical trials and an aide-memoire for those more experienced in this area. For this purpose, it concentrates on the parallel two-group controlled trial with a single outcome measure where patients are randomised individually to one of the two interventions concerned. The second section expands on the individually randomised design in several ways by considering paired designs, repeated assessments of the (same) outcome measure over time, more than two interventions, and non-inferiority trials. It also includes cluster trials, and stepped wedge designs in which groups rather than individuals are randomised to the interventions concerned. The final section deals with genomic targets, feasibility and pilot studies, and a final chapter on miscellaneous topics including adaptive designs, large simple trials and very small trials with new additions describing alpha spending functions and the predictive probability test for use in interim analyses"--
_cProvided by publisher.
650 2 _aRandomized Controlled Trials as Topic
_xmethods
_9143145
650 2 _aBiomedical Research
_xmethods
_9128330
650 2 _aResearch Design
_999434
655 0 _aElectronic books
_92032
700 1 _aFayers, Peter M.
_eauthor
_9143146
700 1 _aTai, Bee Choo
_eauthor
_9143147
856 4 0 _zOnline access link to the resource
_uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119524687
942 _2NLM
_cEBK